Importantly, Rb1 treatment significantly decreased the expression of IL-6, IL-1β, p-IKK, SOCS3 and PTP1B (-14%, -31%, -15%, -20% and -14% respectively; p<0.05; Fig. 4) in the hypothalamus compared with HF control mice. This evidence concerns the gene IL1B and hydrops fetalis.